Medinova Diagnostic Services Limited (MEDINOV.BO)
INR 38.4
(-2.71%)
INR 38.4
(-2.71%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 26.65 Million | 14.19 Million | 13.52 Million | 16.85 Million | 12.39 Million |
| Net Income | 22.78 Million | 19 Million | 27.96 Million | 19.14 Million | -2.58 Million |
| Depreciation & Amortization | 1.27 Million | 3.25 Million | 5.46 Million | 7.16 Million | 9.51 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -3.11 Million | -6.16 Million | -14.48 Million | -12.72 Million | -2.04 Million |
| Other non-cash items | 4.94 Million | -1.15 Million | -381 Thousand | 2.89 Million | 7.51 Million |
| Investing Cash Flow | -2.05 Million | -3.39 Million | -18.36 Million | -618 Thousand | -1.57 Million |
| Investments in PPE | -2.14 Million | -3.86 Million | -1.69 Million | -1.85 Million | -229 Thousand |
| Acquisitions | - | - | -17 Million | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 94 Thousand | 1000.00 | -17 Million | 1.23 Million | -1.34 Million |
| Financing Cash Flow | -13.24 Million | -8.54 Million | 3.11 Million | -13.74 Million | -10.72 Million |
| Debt repayment | -7.5 Million | -6.34 Million | -19.13 Million | -11.74 Million | -1.43 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -5.74 Million | -8.54 Million | -21.64 Million | -3.07 Million | -9.29 Million |
| Accounts receivables | 970 Thousand | -1.85 Million | 3.12 Million | -3.53 Million | 163 Thousand |
| Accounts payables | - | - | - | - | - |
| Inventory | -136 Thousand | 546 Thousand | -305 Thousand | -654 Thousand | 145 Thousand |
| Other working capital | -3.26 Million | 3.79 Million | -5.91 Million | -4.07 Million | -2.34 Million |
| Cash at beginning of period | 7.79 Million | 5.54 Million | 3.16 Million | 676 Thousand | 582 Thousand |
| Cash at end of period | 19.14 Million | 7.79 Million | 1.43 Million | 3.16 Million | 676 Thousand |
| Capital Expenditure | -2.14 Million | -3.86 Million | -1.69 Million | -1.85 Million | -229 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 11.35 Million | 2.25 Million | -1.73 Million | 2.49 Million | 94 Thousand |
| Free Cash Flow | 24.5 Million | 10.32 Million | 11.82 Million | 15 Million | 12.16 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.22 Million | 5.98 Million | 22.78 Million | 4.02 Million | 6.64 Million | 3.33 Million |
| Depreciation & Amortization | - | - | 1.27 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -3.11 Million | - | - | - |
| Other non-cash items | -4.22 Million | -5.98 Million | 4.94 Million | -4.02 Million | -6.64 Million | -3.33 Million |
| Investing Cash Flow | - | - | -2.05 Million | - | - | - |
| Investments in PPE | - | - | -2.14 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 94 Thousand | - | - | - |
| Financing Cash Flow | - | - | -13.24 Million | - | - | - |
| Debt repayment | - | - | -7.5 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -5.74 Million | - | - | - |
| Accounts receivables | - | - | 970 Thousand | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -136 Thousand | - | - | - |
| Other working capital | - | - | -3.26 Million | - | - | - |
| Cash at beginning of period | - | - | 7.79 Million | - | - | - |
| Cash at end of period | - | - | 19.14 Million | - | - | - |
| Capital Expenditure | - | - | -2.14 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 11.35 Million | - | - | - |
| Free Cash Flow | - | - | 24.5 Million | - | - | - |
7359
PGSUS
LAND
AMMCF
000949
000917